Potential underlying mechanisms include nNOS uncoupling, which has been documented in conditions of oxidative stress, such as atherosclerosis, and increased levels of the endogenous NO synthase inhibitor asymmetric dimethylarginine, which has been observed in conditions such as diabetes and hypertension (29). The gene discussed is NOS1; the disease is atherosclerosis.